USANA Health Sciences Inc
€16.76
EUR
Last updated on --.
24h volume112.92K
24h highest16.7528 EUR
24h lowest15.9014 EUR
24h Price movement+6.79%
USNA recent prices
24 Hours
+6.79%+€1.066
30 days
-2.54%-€0.4257
60 days
+7.61%+€1.156
90 days
-11.59%-€2.146
Key data
Previous close15.7036 EUR
Market cap288.03M EUR
Volume112.92K
P/E ratio37.750000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.41280 EUR
Net income (FY)7.87M EUR
Revenue (FY)796.30M EUR
Last report date12 May 2026
About USANA Health Sciences Inc
HeadquartersSALT LAKE CITY
Employees (FY)1.57K
Revenue per employee (FY)507.20K EUR
Net income per employee (FY)5.01K EUR
Listed onNew York Stock Exchange
USNA conversion tables
 |  |
|---|---|
| 0.5 USNA | 8.384 EUR |
| 1 USNA | 16.76 EUR |
| 5 USNA | 83.84 EUR |
| 10 USNA | 167.69 EUR |
| |
|---|---|
| 0.5 EUR | 0.029815 USNA |
| 1 EUR | 0.059631 USNA |
| 5 EUR | 0.29815 USNA |
| 10 EUR | 0.59631 USNA |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
USNA is trading at €16.76, +6.79% over the last 24 hours. Track live moves on the price chart at the top of this page.
The USNA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. USNA is currently trading at €16.76, +6.79% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on USNA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. USNA's P/E ratio is currently 37.750000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from USNA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against USNA's historical range and other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector.
USANA Health Sciences Inc's market cap is currently 288.03M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume112.92K
24h highest16.7528 EUR
24h lowest15.9014 EUR
24h Price movement+6.79%
Start trade with USNA Perpetual
Sign up to trade